Terazosin Hydrochloride

Product NDC
71610-854
11-digit product format
716100854
Labeler code
71610
Product ID
71610-854_214d9180-c434-330d-e063-6394a90a795c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Terazosin Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA074823
Marketing category
ANDA
Marketing start
2020-06-30
Substance
TERAZOSIN HYDROCHLORIDE
Active strength
1 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
D32S14F082TERAZOSIN HYDROCHLORIDE70024-40-7TERAZOSIN HYDROCHLORIDE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71610-854-307161008543030 CAPSULE in 1 BOTTLE (71610-854-30) 30 capsule2024-09-03NoNoHistorical
71610-854-537161008545360 CAPSULE in 1 BOTTLE (71610-854-53) 60 capsule2024-09-03NoNoHistorical
71610-854-607161008546090 CAPSULE in 1 BOTTLE (71610-854-60) 90 capsule2024-09-03NoNoHistorical
71610-854-8071610085480180 CAPSULE in 1 BOTTLE (71610-854-80) 180 capsule2024-09-03NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Terazosin Capsules, USPAphena Pharma Solutions - Tennessee, LLC2024-09-04HUMAN PRESCRIPTION DRUG LABEL1